Cargando…
Therapeutic advances in overcoming intrauterine growth restriction induced metabolic syndrome
Intrauterine growth restriction (IUGR) remains a great public health challenge as it affects neonatal survival and influences their normal biological development and metabolism. Several clinical researches have revealed the occurrence of metabolic syndrome, such as insulin resistance, obesity, type...
Autores principales: | Mutamba, Alpha Kalonda, He, Xiaori, Wang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875160/ https://www.ncbi.nlm.nih.gov/pubmed/36714657 http://dx.doi.org/10.3389/fped.2022.1040742 |
Ejemplares similares
-
Aberrant Hematopoiesis and Morbidity in Extremely Preterm Infants With Intrauterine Growth Restriction
por: Reibel, Nora J., et al.
Publicado: (2021) -
Reversal of Opioid Intoxication in an Infant With Intrauterine Growth Restriction With a Single Dose of Naloxone
por: Timalsina, Utsav, et al.
Publicado: (2021) -
Case report: Tackling the complexities of an extremely premature newborn with intrauterine growth restriction and congenital metabolic disorders through a multidisciplinary approach
por: Roșca, Ioana, et al.
Publicado: (2023) -
The Nexus of Prematurity, Birth Defects, and Intrauterine Growth Restriction: A Role for Plac1-Regulated Pathways
por: Fant, Michael E., et al.
Publicado: (2014) -
Intrauterine Gardnerella vaginalis Infection Results in Fetal Growth Restriction and Alveolar Septal Hypertrophy in a Rabbit Model
por: Cheah, Fook-Choe, et al.
Publicado: (2021)